BERTOLOTTI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 25.586
AS - Asia 12.414
EU - Europa 11.849
SA - Sud America 1.745
AF - Africa 250
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 15
Totale 51.890
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.162
SG - Singapore 4.104
CN - Cina 3.452
GB - Regno Unito 3.127
IT - Italia 3.082
HK - Hong Kong 1.557
BR - Brasile 1.301
VN - Vietnam 1.230
DE - Germania 1.028
SE - Svezia 955
FI - Finlandia 783
UA - Ucraina 587
FR - Francia 531
TR - Turchia 481
RU - Federazione Russa 462
PL - Polonia 386
KR - Corea 328
CA - Canada 261
IN - India 239
BG - Bulgaria 228
NL - Olanda 195
ID - Indonesia 167
AR - Argentina 164
BD - Bangladesh 146
IQ - Iraq 104
JP - Giappone 98
MX - Messico 87
ES - Italia 80
IE - Irlanda 72
EC - Ecuador 64
ZA - Sudafrica 59
PK - Pakistan 58
VE - Venezuela 53
AT - Austria 51
MA - Marocco 50
AE - Emirati Arabi Uniti 49
BE - Belgio 49
CL - Cile 45
CO - Colombia 45
PH - Filippine 44
MY - Malesia 43
UZ - Uzbekistan 43
TW - Taiwan 39
SA - Arabia Saudita 36
CZ - Repubblica Ceca 32
CH - Svizzera 31
AU - Australia 25
JO - Giordania 25
LT - Lituania 25
PE - Perù 25
ET - Etiopia 24
EG - Egitto 23
TH - Thailandia 23
PY - Paraguay 21
IR - Iran 20
DZ - Algeria 19
RO - Romania 19
TN - Tunisia 19
CR - Costa Rica 17
GR - Grecia 17
KE - Kenya 16
UY - Uruguay 16
OM - Oman 15
NP - Nepal 14
AZ - Azerbaigian 11
BY - Bielorussia 11
IL - Israele 11
PA - Panama 11
TT - Trinidad e Tobago 11
BO - Bolivia 10
PT - Portogallo 10
SI - Slovenia 10
MK - Macedonia 9
NG - Nigeria 9
RS - Serbia 9
DO - Repubblica Dominicana 8
EU - Europa 8
SY - Repubblica araba siriana 8
AL - Albania 7
JM - Giamaica 7
KG - Kirghizistan 7
KZ - Kazakistan 7
LU - Lussemburgo 7
NI - Nicaragua 7
PS - Palestinian Territory 7
BH - Bahrain 6
DK - Danimarca 6
HU - Ungheria 6
KW - Kuwait 6
MD - Moldavia 6
NO - Norvegia 6
NZ - Nuova Zelanda 6
SK - Slovacchia (Repubblica Slovacca) 6
SN - Senegal 6
AM - Armenia 5
BA - Bosnia-Erzegovina 5
CY - Cipro 5
HN - Honduras 5
LB - Libano 5
QA - Qatar 5
Totale 51.820
Salva come PNG Salva come JPEG
Città #
Singapore 2.773
Fairfield 2.378
Santa Clara 2.365
Ashburn 2.181
Southend 2.013
Hong Kong 1.538
Woodbridge 1.495
Chandler 1.322
Houston 1.309
Jacksonville 1.044
Hefei 984
Seattle 887
Dearborn 829
Wilmington 823
Ann Arbor 820
San Jose 819
Cambridge 786
Beijing 630
Helsinki 577
London 572
Nyköping 571
Chicago 551
Los Angeles 462
Ho Chi Minh City 404
Modena 380
Warsaw 370
Seoul 315
The Dalles 304
San Diego 296
Hanoi 280
Izmir 278
Princeton 241
New York 238
Milan 235
Sofia 216
Council Bluffs 201
Salt Lake City 197
Eugene 187
Lauterbourg 186
Shanghai 161
Moscow 143
Buffalo 133
Munich 131
São Paulo 125
Rome 121
Tampa 116
Elk Grove Village 111
Des Moines 107
Jakarta 104
Dallas 100
Bologna 97
Toronto 93
Fremont 83
Tokyo 77
Orem 76
Frankfurt am Main 75
Redwood City 75
Boardman 71
Guangzhou 71
Columbus 66
Dublin 62
Haiphong 62
Bremen 57
Grafing 57
Da Nang 55
Falls Church 54
Sterling 53
Brooklyn 50
Baghdad 49
Phoenix 47
Brussels 43
Parma 43
Montreal 41
Turku 40
North York 39
San Mateo 39
Lancaster 38
Nuremberg 38
Amsterdam 36
Denver 36
Florence 36
Mountain View 35
Kunming 34
Tashkent 34
Chennai 33
Norwalk 33
Turin 33
Atlanta 32
Kent 32
Miami 32
Nanjing 32
Padova 32
Manchester 31
San Francisco 30
Rio de Janeiro 27
Zhengzhou 27
Naples 26
Redondo Beach 26
Stockholm 26
Belo Horizonte 25
Totale 35.748
Salva come PNG Salva come JPEG
Nome #
MoCA 7.1: Multicenter Validation of the First Italian Version of Montreal Cognitive Assessment 991
ABCB4 and ABCB11 mutations in intrahepatic cholestasis of pregnancy in an Italian population 697
17 Beta-estradiol prevents cytotoxicity from hydrophobic bile acids in HepG2 and WRL-68 cell cultures 465
Increased appearance rate of 27-hydroxycholesterol in vivo in hypercholesterolemia: A possible compensatory mechanism. 445
Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes 411
Changes in bile acid synthesis in gallstone disease: cause, consequence or neither? 408
Gallstone disease in non-alcoholic fatty liver: Prevalence and associated factors 407
Decreased hepatic expression of PPAR-gamma coactivator-1 in cholesterol cholelithiasis. 405
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 396
Effect of liver cirrhosis on the systemic availability of naltrexone in humans 395
Age-related changes in bile acid synthesis and hepatic nuclear receptor expression 394
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (Internal and Emergency Medicine, (2018), 13, 5, (651-660), 10.1007/s11739-018-1835-9) 374
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 373
Efficacy of a multiple-component and multifactorial personalized fall prevention program in a mixed population of community-dwelling older adults with stroke, Parkinson's Disease, or frailty compared to usual care: The PRE.C.I.S.A. randomized controlled trial 365
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 364
Sofosbuvir-based therapy cures hepatitis C virus infection after prior treatment failures in a patient with concurrent lymphoma 364
Suppression of bile acid synthesis, but not of hepatic cholesterol 7alpha-hydroxylase expression, by obstructive cholestasis in humans 358
Drug prescription and delirium in older inpatients: Results from the nationwide multicenter Italian Delirium Day 2015-2016 358
APOE MODENA : A NOVEL APOE MUTANT CAUSING LIPOPROTEIN GLOMERULOPATHY 354
Multidisciplinary approach to the treatment of metabolic and morphologic alterations of HIV-related lipodystrophy 352
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 351
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 349
Serum time course of naltrexone and 6 beta-naltrexol levels during long term treatment in drug addicts 346
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 342
Age-associated alterations in cholesterol homeostasis: evidence from a cross-sectional study in a Northern Italy population. 341
Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels? 341
Physical exercise for late life depression: effects on cognition and disability 339
Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: Prevalence and correlates 336
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 336
Correlation between plasma levels of 7alpha-hydroxy-4-cholesten-3-one and cholesterol 7alpha-hydroxylation rates in vivo in hyperlipidemic patients 334
Appropriateness of oral anticoagulant therapy prescription and its associated factors in hospitalized older people with atrial fibrillation 332
Endocrine and liver interaction: the role of endocrine pathways in NASH 331
Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease 329
Telomere length elongation after weight loss intervention in obese adults 327
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 326
Novel genetic mutation in apolipoprotein E2 homozygosis and its implication in organ donation: a case report 324
Genetic polymorphisms in non-alcoholic fatty liver disease: Interleukin-6-174G/C polymorphism is associated with non-alcoholic steatohepatitis 319
La clinica metabolica per il trattamento della lipodistrofia 316
Bile acids and nonalcoholic fatty liver disease: An intriguing relationship 315
Analgesic drug taking: Beliefs and behavior among headache patients 313
Nonalcoholic fatty liver disease and aging: epidemiology to management 311
The relationship between age and fat infiltration in liver and muscle 310
Nuclear receptors as potential molecular targets in cholesterol accumulation conditions: Insights from evidence on hepatic cholesterol degradation and gallstone disease in humans 308
Comparative cytotoxic and cytoprotective effects of taurohyodeoxycholic acid (THDCA) and tauroursodeoxycholic acid (TUDCA) in HepG2 cell line. 304
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 303
Risk of birth defects associated with maternal pregestational diabetes. 301
Lung fibrosis, bone marrow fibrosis and liver cirrhosis: A Short Telomere Syndrome or a casual association? 298
Lipoprotein glomerulopathy associated with a mutation in apolipoprotein e 296
Regulation of bile acid synthesis in humans: effect of treatment with bile acids, cholestyramine or simvastatin on cholesterol 7 alpha-hydroxylation rates in vivo. 293
In Vivo Degradation of Cholesterol to Bile Acids Is Reduced in Patients Receiving Parenteral Nutrition. 293
Nutraceutical approach for the management of cardiovascular risk – a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study 290
INCREASED 27-HYDROXYLATION OF CHOLESTEROL IN PRIMARY HYPERCHOLESTEROLEMIA 290
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 288
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI 285
Advances in the comprehension of the pathophysiology of bile secretion 284
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 284
Predictive factors of lack of response to antiviral therapy among in patients with recurrent hepatitis C after liver transplantation. 281
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 281
Olanzapine metabolic side effects: a weight gain issue? 280
Il pool degli acidi biliari quale regolatore del metabolismo epatico del colesterolo: sintesi degli acidi biliari. 279
Risk for cardiovascular events in an Italian population of patients with type 2 diabetes 278
Omega-3 Fatty Acids and Neurodegenerative Diseases: New Evidence in Clinical Trials 277
Hepatic nuclear receptors in human cholelithiasis: A link with insulin resistance? 276
Is cholangiocarcinoma another complication of insulin resistance: A report of three cases 273
Liver X receptors and copper metabolism: New frontiers for the oxysterol receptors 273
Effects of cholecalciferol supplementation in patients with stable heart failure and low vitamin D levels (ECSPLOIT-D). A double-blind, randomized, placebo-controlled pilot study 272
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 271
Anatomia e fisiologia delle vie biliari 269
Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study 264
Case of an old man with aortic dissection type A and enlarging meningioma 261
Disposition of naproxen after oral administration during and between migraine attacks. 260
Review article: effect of bile salt pool composition on hepatic and biliary functions 260
Recommendations for Cardiovascular Prevention During the Sars-Cov-2 Pandemic: An Executive Document by the Board of the Italian Society of Cardiovascular Prevention 260
Effects of acute changes of bile acid pool composition on biliary lipid secretion 258
Bile acid structure and regulation of biliary protein secretion and composition in man 255
The use of stable and radioactive sterol tracers as a tool to investigate cholesterol degradation to bile acids in humans in vivo 255
Effect of ursocholic acid on bile lipid secretion and composition 252
MOLECULAR REGULATION OF STEROL METABOLISM BY BILE ACIDS IN CULTURED HUMAN HEPATOCYTES 251
Effect of taurohyodeoxycholic acid on biliary lipid secretion in humans 250
PHARMACOKINETIC OF REDUCED GLUTATHIONE IN MAN - EFFECT ON PLASMA CYSTEINE AND THIOL COMPOUNDS 249
REGULATION OF HEPATIC CHOLESTEROL-METABOLISM IN THE RAT IN-VIVO. EFFECT OF A SYNTHETIC FAT-FREE DIET ON STEROL SYNTHESIS AND LOW-DENSITY-LIPOPROTEIN TRANSPORT 247
Drug-Induced Liver Injury - Types and Phenotypes 246
NAFLD AND TYPE 2 DIABETES: A GENETIC OR METABOLIC ISSUE? 245
Variable phenotypic expression of homozygous familial hypobetalipoproteinaemia due to novel APOB gene mutations 245
Executive Summary of the 2018 Joint Consensus Document on Cardiovascular Disease Prevention in Italy 243
Do diabetes and obesity promote hepatic fibrosis in familial heterozygous hypobetalipoproteinemia? 243
PHARMACOKINETICS OF TIAPROFENIC ACID AFTER ORAL-ADMINISTRATION IN FASTING PATIENTS DURING AND BETWEEN MIGRAINE ATTACKS 242
Influence of age and sex on serum concentrations of total dimeric activin A 242
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 241
Hypertensive disease in the elderly: Predictors of clinical evolution in a follow-up study 240
Use of oral anticoagulant drugs in older patients with atrial fibrillation in internal medicine wards 239
Review article: hyperlipidaemia and cardiovascular risk 236
Associated factors to post-operative delirium in patients with hip fractures: an orthogeriatric experience. 236
ESTIMATION OF CARDIOVASCULAR RISK IN TYPE 2 DIABETES 235
Patogenesi della colelitiasi. I. Colelitiasi colesterinica. 234
Effect of diabetic autonomic neuropathy on gallbladder kinetics in insulin dependent diabetic patients 234
BILE CHANGES DURING TREATMENT WITH DEOXYCHOLIC-ACID - REPLY 232
Cholesterol metabolism in gallstone disease .Preliminary evidence from the analysis of circulating markers of sterol homeostasis 232
Short-term effects of simvastatin on bile acid synthesis and biliary lipid secretion in human subjects. 231
Nonalcoholic fatty liver disease induced by leuprorelin acetate 231
Totale 31.220
Salva come PNG Salva come JPEG
Categoria #
all - tutte 197.033
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 197.033
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021536 0 0 0 0 0 0 0 0 0 0 342 194
2021/20224.377 183 479 311 389 101 218 314 266 552 243 808 513
2022/20233.991 417 361 312 350 448 576 102 430 510 74 218 193
2023/20242.853 128 163 184 271 527 231 366 339 103 111 135 295
2024/20258.969 320 152 215 638 1.816 1.277 587 444 876 449 972 1.223
2025/202616.385 996 697 1.426 2.152 3.209 1.669 1.946 842 1.671 1.423 354 0
Totale 52.215